8-Prenylnaringenin: A Natural Therapy for Estrogen Deficiency
8-Prenylnaringenin: A Natural Therapy for Estrogen Deficiency
批准号:
10605701
负责人:
Reilly Enos
金额:
$14.31万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-02-15 至 2025-01-31
关键词:
Administrative SupplementAnti-Inflammatory AgentsBiological AvailabilityCell Culture TechniquesChronic DiseaseClinical TreatmentComplementary and alternative medicineData AnalysesEstrogen ReplacementsEstrogen TherapyEstrogensExposure toFatty acid glycerol estersFemaleGoalsHealthHormone replacement therapyHumulusImmunologyImpairmentIn VitroInflammatoryLinkLupusMalignant NeoplasmsMass Spectrum AnalysisMenopauseMentored Research Scientist Development AwardMentorshipMetabolicModelingMyocardial InfarctionNational Center for Complementary and Integrative HealthNative AmericansNutraceuticalParentsPhenotypePhytoestrogensPlantsPostmenopausePropertyResearchResearch PersonnelResearch SupportRiskScientistTherapeuticTrainingWomanWritingdoctoral studentexperiencefallsmacrophageobesity riskobesity treatmentparent grantresponsible research conductside effectskillsstroke risktherapy development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
All women experience menopause, putting a female at risk for a number of chronic diseases, including an
increased risk of obesity. Although post-menopausal replacement of estrogen (hormone replacement therapy -
HRT) has been shown to be effective at protecting against the metabolic and inflammatory perturbations linked
to estrogen-deficiency, HRT has been shown to pose unwanted health risks including an increased risk of stroke,
heart attack, and a variety of cancers. As such, it has become a priority of the National Center for Complementary
and Integrative Health to invest in the development of therapies that are both safe AND effective at combating
menopause-induced side effects, including excess fat mass accrual and its related negative metabolic and
inflammatory perturbations. The parent K01 project (K01AT010348) is aimed at examining the therapeutic
potential of the potent phytoestrogen from the Humulus Lupus plant (hops), 8-prenylnaringenin (8-PN). The
long-term goal is to develop a safe and effective natural therapy for the clinical treatment of menopause-
associated metabolic impairments and inflammatory-driven health perturbations. For this administrative
supplement, we propose to examine how different modes of administration of 8-PN impact bioavailability of this
potent phytoestrogen as well as elucidate the mechanism(s) by which 8-PN impacts the macrophage phenotype.
Christian Unger, a PhD student of Native American heritage in Dr. Reilly Enos’ lab, will serve as the primary
researcher in this supplementary project. Under the mentorship of Dr. Enos, the PI of the parent grant, Christian
will be exposed to mass spectrometry, nutraceutical bioavailability assessment, large data analysis, as well as
in vitro cell culture models. The research proposed in this supplement falls well within the scope of the research
supported in the parent K01 award. In addition to the research experience Christian will garner from this
supplement, Christian will also receive training in scientific writing, presentation skills, data analysis and
interpretation, complementary and alternative medicine, immunology, and responsible conduct of research. This
supplement will provide Christian with a stepping stone towards his long term goal of becoming a scientist
examining nutraceutical therapies for the treatment of obesity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
8-Prenylnaringenin: A Natural Therapy for Estrogen Deficiency
-
批准号:10557831
-
项目类别:
-
资助金额:$14.32万
-
财政年份:2020
-
负责人:Reilly Enos
-
依托单位:
8-Prenylnaringenin: A Natural Therapy for Estrogen Deficiency
-
批准号:9892455
-
项目类别:
-
资助金额:$14.32万
-
财政年份:2020
-
负责人:Reilly Enos
-
依托单位:
8-Prenylnaringenin: A Natural Therapy for Estrogen Deficiency
-
批准号:10338121
-
项目类别:
-
资助金额:$14.32万
-
财政年份:2020
-
负责人:Reilly Enos
-
依托单位:
Dietary Supplements and Inflammation Phase-2: Isoxanthohumol as a treatment for estrogen-deficient-induced visceral hyperalgesia.
-
批准号:10726247
-
项目类别:
-
资助金额:$29.4万
-
财政年份:2012
-
负责人:Reilly Enos
-
依托单位:
海外基金